Raymond James & Associates Mirati Therapeutics, Inc. Transaction History

Raymond James & Associates

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$39.16 - $88.71 $108,708 - $246,258	-2,776 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$75.82 - $150.97 $5,534 - $11,020	73 Added 2.7%	2,776 $228,000
Q4 2021 Feb 08, 2022	SELL	$132.01 - $190.29 $162,900 - $234,817	-1,234 Reduced 31.34%	2,703 $397,000
Q3 2021 Nov 02, 2021	BUY	$132.13 - $177.45 $307,466 - $412,926	2,327 Added 144.53%	3,937 $696,000
Q2 2021 Aug 11, 2021	SELL	$144.0 - $179.73 $683,712 - $853,358	-4,748 Reduced 74.68%	1,610 $260,000
Q1 2021 May 14, 2021	BUY	$158.92 - $221.61 $33,373 - $46,538	210 Added 3.42%	6,358 $1.09 Million
Q4 2020 Feb 12, 2021	SELL	$162.05 - $240.27 $15,070 - $22,345	-93 Reduced 1.49%	6,148 $1.35 Million
Q3 2020 Nov 04, 2020	BUY	$113.26 - $167.27 $191,862 - $283,355	1,694 Added 37.26%	6,241 $1.04 Million
Q2 2020 Jul 28, 2020	BUY	$72.01 - $120.39 $7,921 - $13,242	110 Added 2.48%	4,547 $519,000
Q1 2020 Apr 21, 2020	SELL	$69.78 - $116.21 $45,566 - $75,885	-653 Reduced 12.83%	4,437 $341,000
Q4 2019 Feb 12, 2020	BUY	$70.76 - $128.86 $360,168 - $655,897	5,090 New	5,090 $656,000
Q3 2019 Nov 07, 2019	SELL	$77.91 - $109.6 $159,170 - $223,912	-2,043 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$59.49 - $104.71 $121,538 - $213,922	2,043 New	2,043 $210,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.